PTPN22 and neoplasm: In this study, we examined the methylation level of seven CpG sites in the selected region of PTPN22 (chr1:114,358,291-114,358,739 [GRCh37/hg19]) and observed that all seven sites exhibited hypermethylation in tumor tissue.